though structurally related, it appears that these two receptors have distinct biological activities. KDR, whose Results and Discussion role in endothelial cell function is defined much better than that of Flt-1, is the dominant signaling receptor Given that most human tumors are of epithelial origin, for VEGF-induced mitogenesis and permeability [11, 12] the epithelial-mesenchymal transition has emerged as because of its strong tyrosine kinase activity. In contrast, a critical step in carcinoma progression [3][4][5]. This tranFlt-1 has weaker tyrosine kinase activity yet exhibits a sition, which is also essential for normal morphogenetic 10-fold higher affinity for binding VEGF [13]. In fact, the processes [6-8], results in reduced cell-cell interactions lack of significant signaling responses in endothelia to and increased motility. Although the molecular mechaFlt-1, and its log-scale higher affinity for VEGF binding, nisms underlying the EMT are currently being elucihave led to the suggestion that this molecule acts as a dated, little attention has been given to the possibility decoy receptor, capable of being either a positive or negative regulator of angiogenesis [13, 14], through an ability to sequester VEGF from signaling through KDR.
Although it was assumed that the two VEGF receptors
Autocrine VEGF/Flt-1 Signaling Is Essential for the Survival of Cells that Have Undergone are expressed almost exclusively on vascular endothelial cells, recent studies have demonstrated both KDR an EMT To establish the validity of the VEGF/Flt-1 autocrine sigand Flt-1 expression in tumor cells, including those derived from pancreatic, prostate, and neuroblastoma naling mechanism, we initially sought to perturb this interaction by using functionally interfering monoclonal cancers [15] [16] [17] . Given this consideration, the possibility arose that a specific VEGF receptor promoted the surantibodies. We allowed the cells to undergo an EMT and treated them with the anti-VEGF antibody 2C3. This vival of LIM 1863 cells that had undergone an EMT. To assess this possibility, we analyzed these cells for Flt-1 antibody blocks the VEGF/KDR interaction with no effect on VEGF/Flt-1 activity [20] . As expected, we observed and KDR expression (Figure 2) . Interestingly, immunoblotting revealed that cells within the organoid strucno impact on cell survival (data not shown). We repeated these experiments by using the monoclonal antibody ture expressed a minor, yet detectable, amount of Flt-1 and that its expression increased significantly after in-KM1732, which binds to the VEGF binding region in Flt-1 and specifically interferes with Flt-1-mediated signaling duction of the EMT (Figure 2A) . Flow cytometry revealed a 4-fold increase in Flt-1 surface expression ( Figure 2B) .
[21]. Between 48 and 72 hr after treatment, we consistently observed an almost synchronous rounding up and This finding was substantiated further by RT-PCR (Figure 2C ), which showed a clear increase in the Flt-1 mesdetachment of cells from the plates. Apoptosis under these conditions was assessed by annexin V-FITC and sage in post-EMT cells. In contrast, LIM 1863 cells do not express any KDR, and the EMT does not result in PI staining ( Figure 3A) . The untreated and control IgG cells exhibited low levels of annexin positivity and coman increased expression of this VEGF receptor ( Figure  2D ). Further, we investigated by RT-PCR whether there parable levels of PI ϩ cells. In stark contrast, anti-Flt-1 treatment resulted in significantly higher levels of apowas upregulation of placental growth factor, the other potential ligand for Flt-1, and found that message levels ptotic and dead cells, as measured by annexin V ϩ /PI Ϫ staining and PI ϩ cells, respectively. The combined data for this cytokine were actually repressed significantly after the transition (data not shown). We and others have indicated that 72 hr after antibody treatment, almost two-thirds of the cells were dead and over one-third of previously shown that transcriptional regulation of Flt-1 is dependent on the Ets-1 transcription factor [18, 19] , those that were alive were apoptotic. The addition of KM1732 to intact organoid cultures had no discernible and we observed a concomitant increase in both expression and activity of this factor as a function of the EMT effect on morphology or survival (data not shown). We conclude from these data that blocking VEGF binding (see Figure S1 in the Supplemental Data available with this article online). This finding provides a mechanistic to Flt-1, at the site of the receptor itself, perturbed an autocrine signaling pathway that promoted cell survival. explanation for EMT-induced Flt-1 receptor expression. Taken together, our results reveal a potential autocrine Of note, this is the first direct demonstration of a survival signaling function for the Flt-1 receptor. signaling pathway for cell survival, mediated through a VEGF/Flt-1 interaction, that is elaborated as a conseTo substantiate this unexpected finding, we next performed a set of experiments with an adenoviral conquence of the EMT. confirmed and quantified by annexin V-FITC and PI tion with a control adenovirus (Ad.LacZ), had no effect staining ( Figure 3E ). In addition, we infected the SWon organoid cell survival ( Figure 3C, upper panel) . How-480 cell line, which also exhibits a poorly differentiated ever, when organoids were induced to undergo EMT, and invasive phenotype, and observed a similar apountreated and Ad.LacZ-infected cells underwent a typiptotic response that was specific for those cells excal conversion. In contrast, the sFlt-1-expressing cells pressing the soluble form of the receptor (data not underwent massive cell death as a consequence of the shown). Moreover, each adenoviral assay using these transition ( Figure 3C, lower panel) . The observation that three colon carcinoma cell lines was performed in the the cells were undergoing apoptosis within this shorter presence of serum (5%), indicating that the autocrine time frame (24 hr) was confirmed by in situ apoptosis VEGF/Flt-1 promotion of cell survival is dominant over staining ( Figure 3D Figure 4C ). In stark con-A key finding of this study is that Flt-1 expression corretrast to the normal epithelium, within the tumor, we oblates with the progression of human colon cancer, as served a strong heterogeneous expression of the Flt-1 predicted by the spheroid EMT model. In Figure 4 , we receptor by the carcinoma (c) cells themselves that was provide the first direct demonstration of Flt-1 protein similar in intensity to the surrounding smooth muscle expression for human carcinoma tissue in vivo, as as-( Figure 4D ). The specificity of this staining was highsessed by immunohistochemistry on matched normal lighted by the observation that Ft-1 expression within and carcinoma samples obtained from patients with colon cancer. Hematoxylin-eosin (H&E) staining of control the smooth muscle fibers (sm) was restricted to the 
